Dysregulation of miR-126/Crk protein axis predicts poor prognosis in gastric cancer patients
Runhua Feng(Shanghai Jiao Tong University), Zhenggang Zhu(Wuhan Center for Disease Control and Prevention), Maneesh Kumarsing Beeharry(Shanghai Jiao Tong University), Min Yan(Zhengzhou University), Bingya Liu(Shanghai Jiao Tong University), Liping Su(Guangdong Provincial People's Hospital), Chen Li(Shanghai Jiao Tong University), Xiaolong Jin(Unknown), Fei Yuan(Shanghai Jiao Tong University), Birendra Kumar Sah(Ruijin Hospital)
Cited by 15
Related Papers
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
|Annals of Oncology|2021|743
IL-6 secreted by cancer-associated fibroblasts promotes epithelial-mesenchymal transition and metastasis of gastric cancer via JAK2/STAT3 signaling pathway
|Oncotarget|2017|400
miR-126 functions as a tumour suppressor in human gastric cancer
|Cancer Letters|2010|298
CD36 mediates palmitate acid-induced metastasis of gastric cancer via AKT/GSK-3β/β-catenin pathway
|Journal of Experimental & Clinical Cancer Research|2019|231
Tumor heterogeneity of gastric cancer: From the perspective of tumor-initiating cell
|World Journal of Gastroenterology|2018|212